Skip to main content
. 2021 Dec 1;9(12):1811. doi: 10.3390/biomedicines9121811

Figure 3.

Figure 3

Kaplan–Meier overall survival (OS) curves, showing the differences in the survival intervals of MM patients with high levels of i-tRF-ProTGG (A), i-tRF-GluCTC (B), i-tRF-HisGTG (C), i-tRF-PheGAA (D), and 3′-tRF-LeuAAG/TAG (E), compared to patients with lower levels of these molecules.